U.S. Uterine Fibroid Treatment Market Analysis-2027

1. U.S. UTERINE FIBROID TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION U.S. Uterine Fibroid Treatment Market - Overview There are several surgical approaches for uterine fibroids treatment for women with symptomatic fibroids to choose from and overcome symptoms such as heavy menstrual bleeding, pelvic pressure, and frequent urination. These procedures include, endometrial ablation, MRI guided procedures, hysterectomy, myomectomy, uterine artery embolization, and radiofrequency ablation, among others. These procedures have various applications. Hysterectomy is for women who have lost their fertility. Different types of devices used for the treatment of uterine fibroids include, power morcellators, hysteroscope, intra uterine devices, catheters, endometrial ablation devices, radiofrequency ablation devices, and other devices. U.S. Uterine Fibroids Treatment Market is estimated to account for US$ 243.5 Mn in terms of value in 2020 and is expected to reach US$ 298.5 Mn by the end of 2027. U.S. Uterine Fibroids Treatment Market: Drivers Widespread availability of diagnostic tests is expected to propel growth of the U.S. uterine fibroids treatment market over the forecast period. For instance, pelvic examination and vaginal ultrasound are widely available and inexpensive diagnostic tests. Vaginal ultrasound is considered gold standard evaluation tool for uterine fibroids, owing to its ability to reconstruct the coronal plane of the uterus by three‐dimensional imaging technology. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/us- uterine-fibroid-treatment-market-3866 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION U.S. Uterine Fibroids Treatment Market: Restraints Stringent regulations and urinary tract injuries are expected to hinder growth of the U.S. uterine fibroids treatment market. Companies that develop, manufacture, and sell medical devices are subject to certain governmental regulations laid down by the U.S. FDA. To receive approval for medical devices, companies must comply with certain regulations, which take a long time. Moreover, usage of minimally invasive procedures in the treatment of uterine fibroids can lead to urinary tract injury among women. Key Takeaways: The U.S. uterine fibroids treatment market was valued at US$ 236.7 Mn in 2019 and is forecast to reach a value of US$ 298.5 Mn by 2027 at a CAGR of 3.0% between 2020 and 2027. Major factors driving the growth of U.S. uterine fibroid treatment market during the forecast period include high incidence among women, and technological advancements in medical devices. Hysterectomy held dominant position in the U.S. uterine fibroids treatment market in 2019, accounting for 79.0% share in terms of value, followed by myomectomy and endometrial ablation, respectively. Uterine fibroids majorly develop in 50% of women, which have led to increased rate of hysterectomy i.e. removal of the uterus. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3866 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends The prevalence of women with non–cavity-distorting uterine fibroids is lower in women with polycystic ovary syndrome than in those with unexplained infertility. For instance, according to a study by Yale University School of Public Health, published in The American Society for Reproductive Medicine’s journal Fertility and Sterility in March 2019, the prevalence of women with non–cavity-distorting uterine fibroids in women with polycystic ovary syndrome was 6.7% compared to 12.4% in those with unexplained infertility. For instance, in January 2020, researchers from Pomeranian Medical University in Szczecin, Poland, reported that use of UPA led to reduced size of myomas and fibroids. U.S. Uterine Fibroids Treatment Market: Competitive Landscape Major players operating in the U.S. uterine fibroids treatment market include, Blue Endo, Boston Scientific Corporation, CooperSurgical, Inc., KARL STORZ SE & Co. KG, Myovant Sciences (Sumitovant Biopharma Ltd.), Halt Medical, Inc., LiNA Medical USA, Merit Medical Systems, Olympus Corporation, and Richard Wolf GmbH. U.S. Uterine Fibroids Treatment Market: Key Developments March 2020: Olympus Corporation announced that an updated guidance from the Food and Drug Administration mandates that laparoscopic power morcellation in gynecological procedures be conducted with an approved containment device Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3866 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved